“Anal%2Bcancer”的搜索结果，显示 31-40 项，共有 12645 项

1. 神经科- 临床试验- 妙佑医疗国际

   :Cohort 1 includes (1) advanced unresectable pancreatic cancer, (2-4) advanced, unresectable breast cancer (up to 6 donors per phenotype: triple negative ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The primary objectives of this study are to determine the maximum tolerated dose/recommended phase 2 dose (MTD/RP2D) of selumetinib + vinblastine for ...

3. HER2 阳性乳腺癌：这是什么病？ - 妙佑医疗国际

   HER2 阳性乳腺癌是一种被称为人表皮生长因子受体2（HER2）的蛋白质检测呈阳性的乳腺癌。 ... 产品与服务. A Book: Beyond Breast Cancer · 立刻捐赠 ... HER2-positive breast ...

4. 神经科- 临床试验- 妙佑医疗国际

   :Cohort 1 includes (1) advanced unresectable pancreatic cancer, (2-4) advanced, unresectable breast cancer (up to 6 donors per phenotype: triple negative ...

5. 外科 - 临床试验- 妙佑医疗国际

   ... Colorectal, and Gastric Cancer Patients. Jacksonville, Fla. The purpose of ... 2 groups of patients with peritoneal carcinomatosis (PC), either due to primary ...

6. 神经科- 临床试验- 妙佑医疗国际

   :Cohort 1 includes (1) advanced unresectable pancreatic cancer, (2-4) advanced, unresectable breast cancer (up to 6 donors per phenotype: triple negative ...

7. 神经科- 临床试验- 妙佑医疗国际

   :Cohort 1 includes (1) advanced unresectable pancreatic cancer, (2-4) advanced, unresectable breast cancer (up to 6 donors per phenotype: triple negative ...

8. Mayo Clinic Cancer Physician Update - July 2022

   Page 1.

9. 您的乳腺癌类型意味着什么- 妙佑医疗国际

   第2 组（鲁米那B 型）。该组包括 ER 阳性、 PR 阴性 ... Niederhuber JE, et al., eds. Cancer of the breast. In: Abeloff's Clinical Oncology. ... A Book: Beyond Breast ...

10. 神经科- 临床试验- 妙佑医疗国际

    :Cohort 1 includes (1) advanced unresectable pancreatic cancer, (2-4) advanced, unresectable breast cancer (up to 6 donors per phenotype: triple negative ...